"Fibrosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Descriptor ID |
D005354
|
| MeSH Number(s) |
C04.557.450.565.590.350 C04.557.450.795.350
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Fibrosarcoma".
This graph shows the total number of publications written about "Fibrosarcoma" by people in this website by year, and whether "Fibrosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fibrosarcoma" by people in Profiles.
-
Primary orbital low-grade fibromyxoid sarcoma - A case report. Indian J Ophthalmol. 2019 Apr; 67(4):568-570.
-
Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):399-406.
-
Fibrosarcoma arising in the paranasal sinus: a clinicopathological and radiological analysis. Dentomaxillofac Radiol. 2018 Jul; 47(6):20170459.
-
Targeted Cancer Therapy Using Fusion Protein of TNFa and Tumor-Associated Fibronectin-Specific Aptide. Mol Pharm. 2017 11 06; 14(11):3772-3779.
-
IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis. Exp Cell Res. 2017 12 01; 361(1):9-18.
-
Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression. IUBMB Life. 2017 11; 69(11):824-833.
-
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models. Br J Cancer. 2017 Aug 22; 117(5):628-638.
-
The effects of gene therapy with granulocyte-macrophage colony-stimulating factor in the regression of tumor masses in fibrosarcoma mouse model. J Cancer Res Ther. 2017 Apr-Jun; 13(2):362-366.
-
Sarcomas with spindle cell morphology. Semin Oncol. 2009 Aug; 36(4):324-37.
-
Chronic infection of Balb/c mice with murine herpesvirus 72 is associated with neoplasm development. Acta Virol. 1996 Nov-Dec; 40(5-6):297-301.